Biology subjects

Cornelison, R. C.

Publications and source records attributed to Cornelison, R. C..

5 recordsLinked to original sources

bioRxiv2025

Fluid shear stress promotes glial-mediated neurotoxicity in vitro via purinergic signaling

Interstitial fluid flow plays a critical role in maintaining function and homeostasis in neural tissue, and dysregulation of this flow due to injury or disease results in mechanical stress that is associated with several neuropathologies, including traumatic brain injury, ischemic stroke, and glioma. Glial cells such as astrocytes and microglia are known to respond to mechanical forces like fluid shear stress but the impact of this stress on their functionality and any subsequent impact on neurons remains poorly defined. To investigate how pathologically high fluid shear stress modulates astrocyte and microglia function and to determine whether glial responses to fluid shear influence neuronal survival and morphology, we applied low pathological levels of fluid shear stress (0.1 dynes/cm2) to cultured human astrocytes and microglia and assessed functional changes including metabolic activity, metabolite release, lipid droplet accumulation, and phagocytic activity. Conditioned media from these glia were then applied to differentiated SH-SY5Y neurons to evaluate effects on cell survival and neurite outgrowth. We then focused on identifying the soluble factor mediating the observed neurotoxicity. We found that fluid shear stress promotes distinct functional responses in astrocytes and microglia, including increased metabolic activity in astrocytes, increased lipid droplet accumulation in microglia, and heightened release of extracellular ATP in both cell types. Exposure to shear-conditioned glial media significantly reduced neuronal survival and neurite length. This neurotoxic effect was abolished by activated charcoal filtration but not by boiling and was prevented through P2x7 receptor inhibition in neurons, suggesting extracellular ATP as a causative agent. These findings indicate that high fluid shear stress promotes glial-mediated neurotoxicity via purinergic signaling. This study helps to characterize glial-neuronal mechanobiological interaction in the context of neuropathology and provides support for targeting purinergic signaling pathways as a therapeutic approach for neuropathologies associated with altered interstitial fluid flow. Statement of significanceGlial cells, until recently merely considered to support neurons, are now known to play critical roles in neural tissue development and function. Astrocytes and microglia play diverse roles in the central nervous system, adopting phenotypes that both promote and resolve pathology. Within brain tissue, disruptions to interstitial fluid flow are associated with brain injury, ischemic stroke, and glioma. This study identifies fluid shear stress as a modulator of glial cell function with downstream neurotoxic consequences. Namely, we found that increased release of extracellular ATP by glial cells under high shear promotes neurotoxicity via P2x7 receptor signaling. These findings help to characterize mechanobiological glial-neuronal communication and lend support for the therapeutic efficacy of P2x7 receptor inhibition in the treatment of neuropathology.

bioengineering↗

bioRxiv2020

A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironment

Glioblastoma is an aggressive brain cancer characterized by diffuse infiltration. Infiltrated glioma cells persist in the brain post-resection where they interact with glial cells and experience interstitial fluid flow. We recreate this infiltrative microenvironment in vitro based on resected patient tumors and examine malignancy metrics (invasion, proliferation, and stemness) in the context of cellular and biophysical factors and therapies. Our 3D tissue-engineered model comprises patient-derived glioma stem cells, human astrocytes and microglia, and interstitial fluid flow. We found flow contributes to all outcomes across seven patient-derived lines, and glial effects are driven by CCL2 and differential glial activation. We conducted a six-drug screen using four outcomes and find expression of putative stemness marker CD71, opposed to viability IC50, significantly predicts murine xenograft survival. Our results dispute the paradigm of viability as predictive of drug efficacy. We posit this patient-centric, infiltrative tumor model is a novel advance towards translational personalized medicine.

bioengineering↗

bioRxiv2019

Platinum chemotherapy induces lymphangiogenesis to prime tissues for tumor metastasis

Chemotherapy has been used to inhibit cancer growth for decades, but emerging evidence shows it can affect the tumor stroma unintentionally promoting cancer malignancy. After treatment of primary tumors, remaining drugs drain via lymphatics. Though all drugs interact with the lymphatics, we know little of their impact on them. Here, we show a previously unknown effect of platinums, a widely used class of chemotherapeutics, to directly induce systemic lymphangiogenesis and activation. These changes are dose-dependent, long-lasting, and occur in healthy and cancerous tissue in multiple mouse models of breast cancer. We saw similar effects in human ovarian and breast cancer patients whose treatment regimens included platinums. Carboplatin treatment of healthy mice prior to mammary tumor inoculation increases cancer metastasis as compared to no pre-treatment. These platinum-induced phenomena could be blocked by VEGFR3 inhibition. These findings have implications for cancer patients receiving platinums and may support the inclusion of anti-VEGFR3 therapy into treatment regimens or differential design of treatment regimens to alter these potential effects. SummaryPlatinum chemotherapy induces VEGFR3-dependent lymphangiogenesis, priming tissues for metastasis of breast cancer. Inhibition of VEGFR3 via antibody blockade can reverse these effects.

cancer biology↗

bioRxiv2018

Convective forces increase CXCR4-dependent glioblastoma cell invasion in GL261 murine model

Glioblastoma is the most common and malignant form of brain cancer. Its invasive nature limits treatment efficacy and promotes inevitable recurrence. Previous in vitro studies have shown that interstitial fluid flow, a factor characteristically increased in cancer, increases glioma cell invasion via CXCR4-CXCL12. It is currently unknown if these effects translate in vivo. Using the therapeutic technique of convection enhanced delivery (CED), we tested if convective flow alters glioma invasion in vivo using the syngeneic GL261 mouse model of glioblastoma. We first confirmed that GL261 invasion in vitro increased under flow in a CXCR4-CXCL12 dependent manner. Additionally, approximately 65.4% and 6.59% of GL261 express CXCR4 and CXCL12 in vivo, respectively, with 3.38% expressing both. Inducing convective flow within implanted tumors indeed increased glioma cell invasion over untreated controls, and administering CXCR4 antagonist AMD3100 (5 mg/kg) effectively eliminated this response. Therefore, glioma invasion is in fact stimulated by convective flow in vivo through CXCR4. We also analyzed patient samples to show that expression of CXCR4 and CXCL12 increase in patients following therapy. These results suggesting that targeting flow-stimulated invasion may prove beneficial as a second line of therapy, particularly in patients chosen to receive convection enhanced drug delivery.

cancer biology↗

bioRxiv2018

Applicability of Drug Response Metrics for Cancer Studies using Biomaterials

Bioengineers have built increasingly sophisticated models of the tumor microenvironment in which to study cell-cell interactions, mechanisms of cancer growth and metastasis, and to test new potential therapies. These models allow researchers to culture cells in conditions that include features of the in vivo tumor microenvironment (TME) implicated in regulating cancer progression, such as ECM stiffness, integrin binding to the ECM, immune and stromal cells, growth factor and cytokine depots, and a 3D geometry more representative of the TME than tissue culture polystyrene (TCPS). These biomaterials could be particularly useful for drug screening applications to make better predictions of efficacy, offering better translation to preclinical in vivo models and clinical trials. However, it can be challenging to compare drug response reports across different platforms and conditions in the current literature. This is, in part, as a result of inconsistent reporting and use of drug response metrics, and vast differences in cell growth rates across a large variety of biomaterial design. This perspective paper attempts to clarify the definitions of drug response measurements used in the field, and presents examples in which these measurements can and cannot be applied. We suggest as best practice to include appropriate controls, always measure the growth rate of cells in the absence of drug, and follow our provided \"decision tree\" matrix when reporting drug response metrics.

bioengineering↗